TY - JOUR
T1 - TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming
AU - Barbet, Gaëtan
AU - Nair-Gupta, Priyanka
AU - Schotsaert, Michael
AU - Yeung, Stephen T.
AU - Moretti, Julien
AU - Seyffer, Fabian
AU - Metreveli, Giorgi
AU - Gardner, Thomas
AU - Choi, Angela
AU - Tortorella, Domenico
AU - Tampé, Robert
AU - Khanna, Kamal M.
AU - García-Sastre, Adolfo
AU - Blander, J. Magarian
N1 - Funding Information:
We thank V. Gillespie for expert pathology on mouse lung tissues. We thank S. Trombetta (Boehringer Ingelheim); K. Rock (University of Massachusetts); P. Cresswell (Yale University); and W. Li, T. M. Moran, D. B. Rubiov and A. Fernandez-Sesma (Icahn School of Medicine at Mount Sinai) for reagents and technical advice. We are grateful to current Blander laboratory members and to H. Gupta, M. A. Blander and S. J. Blander for discussions and support. The ISMMS-Microscopy Shared Resource Facility was supported by grants no. NIH 5R24 CA095823-04, no. S10 RR0 9145-01 and no. NSF DBI-9724504. This work was supported by NIH grants no. AI073899 and no. AI123284 to J.M.B.; an NIH/NIAID Center for Research on Influenza Pathogenesis contract as part of the CEIRS Network no. HHSN266200700010C to A.G.-S., grant nos. AI101820 and AI112318 to D.T., and grant no. AI143861 to K.M.K.; German Research Foundation grants no. SFB 807–Membrane Transport and Communication and no. TA157/7; and by the European Research Council (ERC Advanced Grant no. 789121) to R.T. Support to J.M.B. was also provided by NIH grants no. DK111862 and no. AI127658, the Burroughs Wellcome Fund, and the Leukemia and Lymphoma Society. G.B. has been supported by a fellowship and is currently supported by a career development award from the Crohn’s and Colitis Foundation. T.G. was supported by an American Heart Association pre-doctoral fellowship and NIH grant no. F32CA224438.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2021/4
Y1 - 2021/4
N2 - Classic major histocompatibility complex class I (MHC-I) presentation relies on shuttling cytosolic peptides into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP). Viruses disable TAP to block MHC-I presentation and evade cytotoxic CD8+ T cells. Priming CD8+ T cells against these viruses is thought to rely solely on cross-presentation by uninfected TAP-functional dendritic cells. We found that protective CD8+ T cells could be mobilized during viral infection even when TAP was absent in all hematopoietic cells. TAP blockade depleted the endosomal recycling compartment of MHC-I molecules and, as such, impaired Toll-like receptor–regulated cross-presentation. Instead, MHC-I molecules accumulated in the ER–Golgi intermediate compartment (ERGIC), sequestered away from Toll-like receptor control, and coopted ER-SNARE Sec22b-mediated vesicular traffic to intersect with internalized antigen and rescue cross-presentation. Thus, when classic MHC-I presentation and endosomal recycling compartment–dependent cross-presentation are impaired in dendritic cells, cell-autonomous noncanonical cross-presentation relying on ERGIC-derived MHC-I counters TAP dysfunction to nevertheless mediate CD8+ T cell priming.
AB - Classic major histocompatibility complex class I (MHC-I) presentation relies on shuttling cytosolic peptides into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP). Viruses disable TAP to block MHC-I presentation and evade cytotoxic CD8+ T cells. Priming CD8+ T cells against these viruses is thought to rely solely on cross-presentation by uninfected TAP-functional dendritic cells. We found that protective CD8+ T cells could be mobilized during viral infection even when TAP was absent in all hematopoietic cells. TAP blockade depleted the endosomal recycling compartment of MHC-I molecules and, as such, impaired Toll-like receptor–regulated cross-presentation. Instead, MHC-I molecules accumulated in the ER–Golgi intermediate compartment (ERGIC), sequestered away from Toll-like receptor control, and coopted ER-SNARE Sec22b-mediated vesicular traffic to intersect with internalized antigen and rescue cross-presentation. Thus, when classic MHC-I presentation and endosomal recycling compartment–dependent cross-presentation are impaired in dendritic cells, cell-autonomous noncanonical cross-presentation relying on ERGIC-derived MHC-I counters TAP dysfunction to nevertheless mediate CD8+ T cell priming.
UR - http://www.scopus.com/inward/record.url?scp=85103743757&partnerID=8YFLogxK
U2 - 10.1038/s41590-021-00903-7
DO - 10.1038/s41590-021-00903-7
M3 - Article
C2 - 33790474
AN - SCOPUS:85103743757
SN - 1529-2908
VL - 22
SP - 497
EP - 509
JO - Nature Immunology
JF - Nature Immunology
IS - 4
ER -